Literature DB >> 24125165

Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients.

Roberta Caruso1, Irene Marafini, Silvia Sedda, Giovanna Del Vecchio Blanco, Paolo Giuffrida, Thomas T MacDonald, Gino Roberto Corazza, Francesco Pallone, Antonio Di Sabatino, Giovanni Monteleone.   

Abstract

RCD [refractory CD (coeliac disease)] is characterized by severe symptoms/signs of malabsorption and mucosal damage unresponsive to a GFD (gluten-free diet). The pathogenesis of RCD is not fully understood. In the present paper, we have characterized the mucosal profile of effector cytokines in RCD. Duodenal biopsies were taken from patients with RCD, patients with active CD and normal controls and were analysed for inflammatory cytokines by real-time PCR and ELISA. IFN (interferon)-γ and IL (interleukin)-21 transcripts were increased in active CD patients but not in RCD patients as compared with normal controls, whereas IL-17A RNA was up-regulated in both active CD and RCD. No significant increase in IL-15 transcripts was observed in both active CD and RCD, whereas IL-15 protein was increased in active CD. IL-6 and TNF (tumour necrosis factor)-α were up-regulated only in RCD. As a proof, we present the case of a woman affected by RCD who responded to anti-TNF-α treatment with improvement of malabsorptive symptoms/signs but no healing of mucosal lesions. The findings indicate that the profile of mucosal effector cytokines differs between RCD and active CD and suggest that TNF-α, IL-6 and IL-17A, but not Th1-type cytokines, could drive the detrimental response in this condition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24125165     DOI: 10.1042/CS20130478

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

1.  Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.

Authors:  R Caruso; I Marafini; E Franzè; C Stolfi; F Zorzi; I Monteleone; F Caprioli; A Colantoni; M Sarra; S Sedda; L Biancone; P Sileri; G S Sica; T T MacDonald; F Pallone; G Monteleone
Journal:  Mucosal Immunol       Date:  2014-05-21       Impact factor: 7.313

Review 2.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

Review 3.  Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases.

Authors:  Christian Barmeyer; Michael Fromm; Jörg-Dieter Schulzke
Journal:  Pflugers Arch       Date:  2016-11-30       Impact factor: 3.657

4.  High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.

Authors:  Silvia Sedda; Veronica De Simone; Irene Marafini; Gerolamo Bevivino; Roberta Izzo; Omero Alessandro Paoluzi; Alfredo Colantoni; Angela Ortenzi; Paolo Giuffrida; Gino R Corazza; Alessandro Vanoli; Antonio Di Sabatino; Francesco Pallone; Giovanni Monteleone
Journal:  Immunology       Date:  2016-12-12       Impact factor: 7.397

5.  Immunology of Gut-Bone Signaling.

Authors:  Fraser L Collins; Jonathan D Schepper; Naiomy Deliz Rios-Arce; Michael D Steury; Ho Jun Kang; Heather Mallin; Daniel Schoenherr; Glen Camfield; Saima Chishti; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes.

Authors:  Yvonne M C Kooy-Winkelaar; Dagmar Bouwer; George M C Janssen; Allan Thompson; Martijn H Brugman; Frederike Schmitz; Arnoud H de Ru; Tom van Gils; Gerd Bouma; Jon J van Rood; Peter A van Veelen; M Luisa Mearin; Chris J Mulder; Frits Koning; Jeroen van Bergen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

Review 7.  Th17, intestinal microbiota and the abnormal immune response in the pathogenesis of celiac disease.

Authors:  Clelia Cicerone; Raffaella Nenna; Stefano Pontone
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

8.  TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children.

Authors:  Elisa Rossi; Daniela Basso; Carlo-Federico Zambon; Filippo Navaglia; Eliana Greco; Michela Pelloso; Serena Artuso; Andrea Padoan; Matilde Pescarin; Ada Aita; Dania Bozzato; Stefania Moz; Mara Cananzi; Graziella Guariso; Mario Plebani
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

Review 9.  Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy.

Authors:  Jürgen Stein; Detlef Schuppan
Journal:  Viszeralmedizin       Date:  2014-06

10.  Matrix expansion and syncytial aggregation of syndecan-1+ cells underpin villous atrophy in coeliac disease.

Authors:  Camilla Salvestrini; Mark Lucas; Paolo Lionetti; Franco Torrente; Sean James; Alan D Phillips; Simon H Murch
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.